Illumina

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Type
Public
HQ
San Diego, US
Founded
1998
Employees
4,600 (est)
Illumina was founded in 1998 and is headquartered in San Diego, US

Illumina Locations

San Diego, US
Victoria, CA
Fulbourn, GB
Little Chesterford, GB
Eindhoven, NL
São Paulo, BR
Minato, JP
Singapore, SG
Shanghai, CN
Scoresby, AU
Redwood City, US
Santa Clara, US
San Francisco, US
Madison, US
Beijing, CN

Illumina Metrics

Illumina Summary

Market capitalization

$23.5 B

Closing share price

$161
Illumina's current market capitalization is $23.5 B.

Illumina Financials

Illumina's revenue is $2.22 B in FY, 2015 which is 19.25% increase from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

$1.42 B$1.86 B$2.22 B

Gross profit

$912 M$1.3 B$1.55 B

Operating income

$134 M$515 M$613 M

Operating expense total

$778 M$783 M$936 M

Net Income

$125 M$353 M$457 M

Operating cash flow

$278 M$-75.5 M$133 M

    Illumina Market Value History

    Illumina Online Presence

    Illumina News

    Illumina Company Life

    You may also be interested in